Thursday, February 2, 2012

Podcast: How the New Role of the CRO Affects Patient Enrollment

In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.

For more information about Acurian, visit www.acurian.com.


Posted by at
Labels: , ,